Marco Argenti ran the 2025 TCS New York Marathon and the NYC Half-Marathon this year to raise funds for PanCAN.

Ken Brown ran his third Chicago Sprint Triathlon this year to raise funds for PanCAN, vowing not to let a pancreatic cancer ...

PanCAN Patient Services Case Manager Trishana Horton shares information about stool and tips to have a conversation with your ...

Kansas City Mission Committee volunteer April Schoenberg spoke with Community Engagement Senior Specialist Paula Mukherjee ...

PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...

Recently, representing PanCAN Patient Services as our manager of research and education communication, I joined a group of patient advocates and researchers in Cambridge, UK, for an annual symposium ...

PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors. In this Q&A, Jon shares his personal connection to the cause, his passion ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

“PanCAN PurpleStride is about coming together. It’s not just a walk, but a walk with a purpose.” – Charles F., PurpleStride Team Captain Walk with a purpose at PanCAN PurpleStride, the ultimate walk ...